Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms - Wikidata - awgldk - TriplyDB

Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms

Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms

http://www.wikidata.org/entity/Q28293764

about

The contribution of inherited genotype to breast cancer.The reality of pharmacogenomics: optimizing therapeutic decision making Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus Molecular cloning and functional characterization of the cDNA encoding the murine thiopurine S-methyltransferase (TPMT)Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients.Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.Therapeutic drug monitoring of antimetabolic cytotoxic drugs.Science, medicine, and the future: Pharmacogenetics.LC-MS/MS coupled with stable isotope dilution method for the quantification of 6-thioguanine and S(6)-methylthioguanine in genomic DNA of human cancer cells treated with 6-thioguanine Thiopurine methyltransferase predicts the extent of cytotoxicty and DNA damage in astroglial cells after thioguanine exposure.Pharmacogenetics of cancer therapy: getting personal Autoimmune hepatitis: current challenges and future prospects.Pharmacogenetics and antiepileptic drugs.The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics.Pharmacogenetics in diverse ethnic populations--implications for drug discovery and development.Thiopurine S-methyltransferase (TPMT) pharmacogenetics: three new mutations and haplotype analysis in the Estonian population.Advances in the development of genetic markers for the diagnosis of disease and drug response.Pharmacogenomics: the future of drug therapy.Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?SNPs in cancer research and treatment.Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups Recent developments in the clinical pharmacology of classical cytotoxic chemotherapy.Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populations.Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study.Pharmacogenomics in pediatric leukemia.Therapeutic drug monitoring of cancer chemotherapy.Gene polymorphisms and pharmacogenetics in rheumatoid arthritis Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.Pharmacology and pharmacogenetics of chemotherapeutic agents.Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.Pharmacogenetics: implications for therapy in rheumatic diseases.Cancer pharmacogenomics in children: research initiatives and progress to date.Pharmacogenetics of childhood acute lymphoblastic leukemia.Thiopurine-induced pancreatitis in inflammatory bowel diseases.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.Probing the Association of Pancreatitis in Inflammatory Bowel Disease.Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.

P2860

Q24802434-85B300EE-DEE3-4D76-B1AF-249CD48CAA40 Q24815907-1903F559-3982-475E-B3D7-86F7EE0E3B5E Q28280113-B90E20AA-1B65-4181-B911-B9ABB3DA80B4 Q28367534-66C8D398-BAE5-445A-960B-3328B5D9AD38 Q28587435-8D18B8D8-0D87-40EF-A202-8980D44B9919 Q31150912-F86FFC02-32C9-4E81-AB80-327EA8C8D462 Q33394134-74183E09-73A2-4450-A0D9-1F40E2A1F657 Q33586713-7860C53A-6B37-41FF-B419-7C2CE5E2EABA Q33884661-9E5351DA-38E7-47D7-B5BA-2DBC1CDC9DAF Q34070112-D4471337-ACFA-412A-A684-2729E4C4DE1C Q34117269-174C21F9-4BC4-4465-9E64-3B6BC880250C Q34386321-3E86DFAE-CA2E-4AEE-8818-5AC53BEBBE86 Q34550808-EEF42454-0B57-4617-8FE0-42BC37CA5B7A Q34558112-82781E10-250F-44DF-B089-435A49902607 Q34609157-038BAD7D-74C2-40D7-B4E4-F523F7D63D97 Q34775319-4958265C-98C8-44A8-9F7B-08848C61B39F Q34793050-A7F66B65-B5A7-470A-A0F9-E1E0336327E8 Q34884611-F082938A-ACF7-461E-BD65-6F1E89F1011D Q34952587-0B58F710-7007-4225-BD2D-7E527684D390 Q35135954-EA164817-62B6-4632-A2BF-7399746484DF Q35670196-2E1CA938-9435-4D2C-9FC0-9BCFEF1FC19B Q35826329-25AFE193-222F-4B9C-B00A-4BEFFAC0CA63 Q35827602-DD33642E-8B79-430E-B9AA-D0568FC3DDA9 Q36055251-223A226C-ED58-490B-93A9-C798395B0B1E Q36402208-E78E890F-F5A5-4FFE-95C9-3EFD95C43091 Q36458023-2F414C46-9759-4571-992C-F958B08DCE9C Q36727952-CD162FC4-E4F0-488F-A1B9-D4A9A4460F26 Q37018328-435744DB-E238-4BFC-A2E7-FA8F923A399A Q37214931-9CF9CFA8-1CAC-4BBF-8859-97D019474610 Q37378665-F3E1F0B5-AB36-451D-B093-62E9B07F2B98 Q37500096-8D1F5CD8-EEB7-4AF4-B7CF-92F43A2DAAD0 Q37887337-3D17A765-A616-4225-A548-2504A42EA8E7 Q37913989-D0EF0081-0748-4D40-BD2D-BCE11C3BB686 Q38093137-EA5B4B64-550A-4D7F-913F-D6DE1827E0E5 Q38243175-F6E77107-284B-4B28-8253-4248D96C4AAD Q38286123-74571843-010F-48CD-BD19-1FEA954BE3ED Q38501680-A63FA1AB-FB69-4E9B-8FAA-4DEF144819C6 Q38563075-BF14A21C-F0F8-4F58-8286-958B3828D445 Q38624953-42CD5517-5A10-4F27-9DB5-F57D52816142 Q38855568-F05FF39F-D219-4266-90ED-A5ACE8B52B2F

P2860

Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms

http://www.wikidata.org/entity/Q28293764

description

1996 nî lūn-bûn

@nan

1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@ast

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@en

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@nl

type

label

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@ast

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@en

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@nl

prefLabel

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@ast

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@en

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@nl

P1433

Q28293764-41C2B306-8A6D-4247-9BE3-4E2ABFBD72D0

P1476

Q28293764-04D70F9D-F223-4258-81F2-0E0BAD1D5985

P2093

Q28293764-0554EB16-FAEC-4E59-BE76-E9A5F0E31123

Q28293764-0E77670E-8212-41EC-A9CD-73763909E582

Q28293764-71ECF1CD-C4BE-4DFB-9EED-ED9BB40FB046

Q28293764-88C382C5-94C8-4180-B232-775ADA804541

Q28293764-8AFE01EA-5294-42C8-BDAD-71DE45AA2B1D

Q28293764-AC9483EA-7BB3-46D0-ABD7-D520563EC17D

Q28293764-D60802B2-4CF0-423C-807D-B61631506E07

Q28293764-F6924C47-A25F-42AA-BD8D-A2A042F51334

P304

Q28293764-0FF1B2A1-20F8-4B2F-A99E-7763AA7B1FD6

P31

Q28293764-1CACF90B-EBE0-4D4B-B9A9-1BAC69059100

P356

Q28293764-69ED2B6F-4A14-403B-9317-50FFE398722F

P407

Q28293764-A01CBA25-F092-4D59-8902-FD3AC7D9A852

P433

Q28293764-CBECE574-B4FF-4163-8FAF-271FA5FEA99B

P478

Q28293764-A73AF5E2-FEFB-4937-8F6E-755999ED9177

P577

Q28293764-894A4DC8-CDA5-4BF9-BBC2-278BC8BC3156

P698

Q28293764-749E019B-D455-4D13-9772-F6C8D427F246

P356

00008571-199608000-00001

P1433

Pharmacogenetics and Genomics

P1476

Genetic polymorphism of thiopu ...... tance and molecular mechanisms

@en

P2093

C R Yates

http://www.w3.org/2001/XMLSchema#string

E Y Krynetski

http://www.w3.org/2001/XMLSchema#string

H L Tai

http://www.w3.org/2001/XMLSchema#string

J D Schuetz

http://www.w3.org/2001/XMLSchema#string

M V Relling

http://www.w3.org/2001/XMLSchema#string

M Y Fessing

http://www.w3.org/2001/XMLSchema#string

T Loennechen

http://www.w3.org/2001/XMLSchema#string

W E Evans

http://www.w3.org/2001/XMLSchema#string

P304

279-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00008571-199608000-00001

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

1996-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8873214

http://www.w3.org/2001/XMLSchema#string